| SUNRISE, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- Bioheart, Inc. (BHRT.OB) a leader in the field of stem cell therapy for the treatment of damaged hearts, today announced that it entered into a $3M standby equity purchase agreement, previously announced in October. The Florida investor has agreed to purchase up to $3M of BHRT common stock upon request, subject to certain conditions, including the registration of those shares on a registration statement that has been declared effective by the SEC. Bio...continued BHRT Healthcare Drugs |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment